GB1591873A - Methyl 3-(2-quinoxalinylmethylene)carbazate-n1,n4-dioxides - Google Patents
Methyl 3-(2-quinoxalinylmethylene)carbazate-n1,n4-dioxides Download PDFInfo
- Publication number
- GB1591873A GB1591873A GB764/80A GB76480A GB1591873A GB 1591873 A GB1591873 A GB 1591873A GB 764/80 A GB764/80 A GB 764/80A GB 76480 A GB76480 A GB 76480A GB 1591873 A GB1591873 A GB 1591873A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- compounds
- formula
- quinoxalinylmethylene
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 28
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 125000001589 carboacyl group Chemical group 0.000 claims description 3
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ALHUXMDEZNLFTA-UHFFFAOYSA-N 2-methylquinoxaline Chemical compound C1=CC=CC2=NC(C)=CN=C21 ALHUXMDEZNLFTA-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- -1 sulphonyl group Chemical group 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- SOEMFPLGOUBPJQ-NTUHNPAUSA-N methyl n-[(e)-quinoxalin-2-ylmethylideneamino]carbamate Chemical compound C1=CC=CC2=NC(/C=N/NC(=O)OC)=CN=C21 SOEMFPLGOUBPJQ-NTUHNPAUSA-N 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-M n-aminocarbamate Chemical compound NNC([O-])=O OWIUPIRUAQMTTK-UHFFFAOYSA-M 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003252 quinoxalines Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69626376A | 1976-06-15 | 1976-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1591873A true GB1591873A (en) | 1981-07-01 |
Family
ID=24796354
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB765/80A Expired GB1591874A (en) | 1976-06-15 | 1977-05-18 | N-methoxy-carbonyl-n'-supphonylhydrazines |
| GB764/80A Expired GB1591873A (en) | 1976-06-15 | 1977-05-18 | Methyl 3-(2-quinoxalinylmethylene)carbazate-n1,n4-dioxides |
| GB20800/77A Expired GB1591872A (en) | 1976-06-15 | 1977-05-18 | Process for producing methyl 3-(2-quinoxalinylmethylene) carbazate-n1,n4-dioxides |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB765/80A Expired GB1591874A (en) | 1976-06-15 | 1977-05-18 | N-methoxy-carbonyl-n'-supphonylhydrazines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB20800/77A Expired GB1591872A (en) | 1976-06-15 | 1977-05-18 | Process for producing methyl 3-(2-quinoxalinylmethylene) carbazate-n1,n4-dioxides |
Country Status (31)
-
1977
- 1977-05-16 SE SE7705744A patent/SE428925B/xx not_active IP Right Cessation
- 1977-05-17 CA CA278,574A patent/CA1087616A/en not_active Expired
- 1977-05-18 ZA ZA00772979A patent/ZA772979B/xx unknown
- 1977-05-18 GB GB765/80A patent/GB1591874A/en not_active Expired
- 1977-05-18 GB GB764/80A patent/GB1591873A/en not_active Expired
- 1977-05-18 GB GB20800/77A patent/GB1591872A/en not_active Expired
- 1977-05-20 GR GR53522A patent/GR72289B/el unknown
- 1977-05-20 NZ NZ184167A patent/NZ184167A/xx unknown
- 1977-05-20 IE IE1040/77A patent/IE44684B1/en not_active IP Right Cessation
- 1977-05-25 IL IL52166A patent/IL52166A0/xx unknown
- 1977-05-26 CH CH650777A patent/CH620911A5/fr not_active IP Right Cessation
- 1977-05-26 PH PH19820A patent/PH14866A/en unknown
- 1977-05-27 YU YU1327/77A patent/YU39492B/xx unknown
- 1977-05-30 JP JP6315177A patent/JPS52153986A/ja active Granted
- 1977-05-31 PT PT66618A patent/PT66618B/pt unknown
- 1977-05-31 NL NL7705938.A patent/NL166685C/xx not_active IP Right Cessation
- 1977-05-31 NO NO771903A patent/NO146864C/no unknown
- 1977-05-31 IT IT49637/77A patent/IT1078874B/it active
- 1977-05-31 DE DE19772725023 patent/DE2725023A1/de active Pending
- 1977-05-31 CS CS773581A patent/CS200218B2/cs unknown
- 1977-06-01 DK DK240777AA patent/DK142497B/da unknown
- 1977-06-01 FI FI771742A patent/FI771742A7/fi not_active Application Discontinuation
- 1977-06-01 AT AT387077A patent/AT357562B/de not_active IP Right Cessation
- 1977-06-02 AR AR267928A patent/AR221207A1/es active
- 1977-06-02 DD DD7700199261A patent/DD131371A5/xx unknown
- 1977-06-02 LU LU77474A patent/LU77474A1/xx unknown
- 1977-06-02 DD DD77204377A patent/DD135080A5/xx not_active IP Right Cessation
- 1977-06-13 BG BG036608A patent/BG35595A3/xx unknown
- 1977-06-14 ES ES459750A patent/ES459750A1/es not_active Expired
- 1977-06-14 ES ES459745A patent/ES459745A1/es not_active Expired
- 1977-06-14 SU SU772494213A patent/SU657746A3/ru active
- 1977-06-15 PL PL1977198873A patent/PL105555B1/pl unknown
- 1977-11-09 PH PH20413A patent/PH14481A/en unknown
-
1979
- 1979-11-10 JP JP14596079A patent/JPS5589256A/ja active Granted
-
1980
- 1980-05-06 SE SE8003393A patent/SE437985B/sv not_active IP Right Cessation
- 1980-12-10 NL NL8006697A patent/NL8006697A/nl not_active Application Discontinuation
-
1981
- 1981-09-22 NO NO813221A patent/NO147422C/no unknown
-
1982
- 1982-10-11 SG SG49282A patent/SG49282G/en unknown
-
1983
- 1983-01-13 HK HK18/83A patent/HK1883A/xx unknown
- 1983-01-13 HK HK20/83A patent/HK2083A/xx unknown
- 1983-01-13 HK HK19/83A patent/HK1983A/xx unknown
- 1983-12-30 MY MY230/83A patent/MY8300230A/xx unknown
- 1983-12-30 MY MY229/83A patent/MY8300229A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1111851A (en) | 2-formylquinoxaline-1,4-dioxide cyanoacetylhydrazones process for the preparation thereof and compositions containing same | |
| Dirlam et al. | Synthesis and antibacterial activity of some 3-[(alkylthio) methyl] quinoxaline 1-oxide derivatives | |
| US3493572A (en) | Process for producing quinoxaline-di-n-oxides | |
| GB1591873A (en) | Methyl 3-(2-quinoxalinylmethylene)carbazate-n1,n4-dioxides | |
| US4044130A (en) | Compositions for the control of microorganisms | |
| JPH0631301B2 (ja) | 抗細菌性９−デオキソ―９ａ―アリルおよびプロパルギル―９ａ―アザ―９ａ―ホモエリスロマイシンＡ誘導体 | |
| US4366311A (en) | Novel dianemycin derivative | |
| IE44685B1 (en) | Methyl 3-(2-quinoxalinylmethylene)carbazate-n1,n4-dioxides | |
| US3911011A (en) | 3,5-Dinitroaniline derivatives | |
| GB1561624A (en) | Sulphonylhydrazones of 1,4-dioxo- and 4-osoquinoxaline-2carboxaldehvde | |
| US3966951A (en) | Esters of quinoxaline-1,4-dioxides | |
| CS232703B2 (en) | Production method of new quinoxaline-1,4-dioxide derivatives | |
| RU938559C (ru) | S-Производные 5-амино-6-меркаптопиримидина, обладающие противоопухолевым и цитостатическим действием | |
| US3954775A (en) | Thiazolo(5,4-f)quinoline-8-carboxylic acid derivatives | |
| DE2428157A1 (de) | Verfahren zur herstellung von 2-arylas-triazin-3,5(2h,4h)-dionen | |
| EP0067411A1 (en) | Novel quinolinecarboxylic acid derivative, process for production thereof, and antibacterial agent containing said compound as active ingredient | |
| CA1049518A (en) | 3-imino-1,2,4-benzotriazine-1-oxides | |
| IE43252B1 (en) | Quinoxaline-1,4-dioxides | |
| US3767657A (en) | Process for the preparation of quinoxaline di n oxides | |
| US4174391A (en) | Spiramycin esters | |
| US3074938A (en) | 2,4,5-trichlorophenol cyanine dye compound and process for the preparation thereof | |
| US3047626A (en) | 4-desdimethylamino-6-deoxy-tetracycline derivatives | |
| US3483257A (en) | Conjugated acetylenic ketones and method for preparation of same and use of same | |
| US3991053A (en) | Antibacterial 1,3-dihydrofuro[3,4-b]quinoxaline 4,9-dioxides | |
| US2945062A (en) | N-lower-alkyl-n-nitroso-3, 5-dinitro-o-toluamides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940518 |